Ibandronate Injection Drug Interactions
- Boniva
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
About Ibandronate Injection
Ibandronate injection is used to treat osteoporosis (a condition in which the bones become thin and weak and break easily) in women who have undergone menopause (''change of life;'' end of menstrual periods). Ibandronate is in a class of medications called bisphosphonates.
Read the full Ibandronate Injection drug information pageQuick links
The Bottom Line on Ibandronate Injection
Ibandronate injection helps keep bones from thinning and breaking in women who have been through menopause, by slowing the breakdown of bone. Compared with most medicines, it has fewer documented interactions, and none are rated major, so there is less to keep track of here. The pair worth knowing is with magnesium oxide, a widely used medicine, which is rated moderate and can make ibandronate work less well. Once a year, bring every bottle you have, supplements included, to a pharmacist for a full review.
From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy
Check Ibandronate Injection Against Another Drug or Supplement
Type a drug, a brand name or a supplement. We check it against every documented ibandronate injection interaction, supplements and herbs included.
What Could Happen When Ibandronate Injection Interacts
What the 12 documented ibandronate injection interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.
This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own pages on this site.
Ibandronate Injection Interactions by Severity
Moderate
- Ibandronate Injection and Aluminum Carbonate, Basic Explained Decreased ibandronate effectiveness Details
- Ibandronate Injection and Aluminum Hydroxide Explained Brand names: AlternaGEL, Alu-Cap, Alu-Tab Decreased ibandronate effectiveness Details
- Ibandronate Injection and Aluminum Oxide Explained Decreased ibandronate effectiveness Details
- Ibandronate Injection and Aluminum Phosphate Explained Decreased ibandronate effectiveness Details
- Ibandronate Injection and Calcium Explained Decreased ibandronate effectiveness Details
- Ibandronate Injection and Dihydroxyaluminum Aminoacetate Explained Decreased ibandronate effectiveness Details
- Ibandronate Injection and Dihydroxyaluminum Sodium Carbonate Explained Decreased ibandronate effectiveness Details
- Ibandronate Injection and Iron Explained Reduced bisphosphonate absorption Details
- Ibandronate Injection and Magnesium Carbonate Explained Decreased ibandronate effectiveness Details
- Ibandronate Injection and Magnesium Hydroxide Explained Brand names: Milk Of Magnesia, Pedia-Lax, Pedia-Lax Chewable Decreased ibandronate effectiveness Details
- Ibandronate Injection and Magnesium Oxide Explained Brand names: Mag-Ox, Maox, Uro-Mag Decreased ibandronate effectiveness Details
- Ibandronate Injection and Magnesium Trisilicate Explained Decreased ibandronate effectiveness Details
Look Up Another Drug
Still Have Questions About Ibandronate Injection?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
The References Behind Ibandronate Injection’s Interactions
The 73 sources our ibandronate injection interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →
- Hadji P, Aapro M, Al-Dagri N, et al: Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: an updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. J Bone Oncol 2025; 53:100694. PubMed
- Product Information: BONIVA(R) oral tablets, ibandronate sodium oral tablets. Genentech USA, Inc. (per FDA), South San Francisco, CA, 2016. DailyMed
- Product Information: BONIVA(R) intravenous injection, ibandronate intravenous injection. Genentech USA, Inc. (per FDA), South San Francisco, CA, 2015. DailyMed
- Thie'baud D, Burckhardt P, Kriegbaum H, et al: Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis. Am J Med 1997; 103:298-307. PubMed
- Delmas PD, Adami S, Strugala C, et al: Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum 2006; 54(6):1838-1846. DOI
- Eisman JA, Civitelli R, Adami S, et al: Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J Rheumatol 2008; 35(3):488-497.
- Miller PD, McClung MR, Macovei L, et al: Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res 2005; 20(8):1315-1322. PubMed
- Miller PD, Recker RR, Reginster JY, et al: Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study. Osteoporos Int 2012; 23(6):1747-1756. DOI
- Miller PD, Epstein S, Sedarati F, et al: Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study. Curr Med Res Opin 2008; 24(1):207-213. PubMed
- Grotz W, Nagel C, Poeschel D, et al: Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 2001; 12:1530-1537. DOI